7210 J . Org. Chem., Vol. 65, No. 21, 2000
Notes
phenylglycinol 3 (1.5 g, 11 mmol) was dissolved in 4% citric acid
buffer (50 mL). A solution of 4 (3 g, 20 mmol) in citric buffer (50
mL) was added followed by potassium cyanide (1 g, 15 mmol).
After stirring overnight, the reaction mixture was neutralized
with NaHCO3 and concentrated under reduced pressure. The
residue was dissolved in boiling MeOH, the resulting suspension
filtered over a pad of silica gel, and the filtrate evaporated. The
oily crude mixture was dissolved in MeOH and treated, under
vigorous stirring, with ZnBr2 (500 mg) for 3 h before being
evaporated in vacuo and submitted to a flash chromatography.
Elution with CH2Cl2/MeOH (95:5) gave 1.5 g (45%) of compound
1 and small amounts of diasteromer 5 (175 mg, 5%). Compound
F igu r e 3.
1,5-imino-1,5,6-trideoxy-D-glucitol 1111 (Figure 3). These
6-amino analogues of 1-deoxymannojirimycin and 1-deoxy-
nojirimycin were obtained in multistep syntheses. While
the δ values for C-2, C-3, C-5, C-6, and C-7 are very close
in the 13C NMR spectra of both 9 and 11, the shift
difference for C-4 (9: 69.3 ppm, 11: 77.4 ppm) is
suggestive of an 1,3-diaxial relationship between the
amino chain at C-2 and the proton attached at C-4 in
1 crystallized from THF: mp ) 182-185 °C; [R]25 _139 (c ) 1
D
1
in MeOH); H NMR (300 MHz, CDCl3/DMSO-d6 2:1, 25 °C): δ
3.5-3.6 (m, 1H), 3.66 (t, J ) 8 Hz, 1H), 3.76 (d, J ) 5.5 Hz, 1H),
3.88 (t, J ) 8 Hz, 1 H), 4.02 (d, J ) 7.5 Hz, 1H), 4.23 (t, J ) 8
Hz, 1H), 5.03 (d, J ) 3.5 Hz, 1H), 5.20 (d, J ) 4 Hz, 1H), 5.46
(d, J ) 4 Hz, 1H), 7.2-7.4 (m, 5H); 13C NMR (75 MHz, CD3OD,
25 °C) δ 51.7, 64.0, 71.1, 74.7, 75.1, 75.7, 92.9, 114.9, 128.4, 129.5,
129.8, 137.1; MS (CI, CH4) m/z 277 (M + 1)+; HRMS (CI, CH4)
m/z (M + 1)+; Calcd for C14H17N2O4: 277.1188, Found: 277.1176.
Anal. Calcd for C14H16N2O4: C, 60.86; H, 5.84; N,10.14. Found:
C, 60.70; H, 5.71; N, 10.20.
1
compound 9. Furthermore, a direct comparison of the H
NMR spectra of the HCl salts of 9 and 10 was very
informative. Indeed, the H-2 resonance at 3.75 ppm (3.46
ppm for 10)12 was a strong argument for an equatorial
proton as well as the coupling constants (td, J ) 6 and 3
Hz). The signal at 4.27 ppm for the equatorial proton H-5
in the spectrum of 9,11 was observed at 3.92 ppm for 9 as
a result of an axial position. This (2R,3S,4S,5R)-2-
(aminomethyl)piperidine-3,4,5-triol 9 obtained in a two-
step synthesis constitutes a new stereomer of the amino
analogue (11, (2R,3R,4R,5S)-2-(aminomethyl)piperidine-
1,3,5-triol)12 of natural 1-deoxynojirimycin (Figure 1).2
Finally, the same reaction was performed on the minor
compound 5 in order to synthesize the amino derivative
11 related to the parent azasugar deoxynojirymicine.2
Indeed, compound 11 was obtained quantitatively from
5 and showed identical physical data to those previously
reported.11b Although performed on a minor reaction
compound, this short synthesis favorably compares with
the already published method11b which needs 11 steps
for the same yield approximately.
Among the multiple ways for synthesizing polyhy-
droxylated piperidines alkaloids and analogues, the well-
established CN(R,S) method could provide a short and
efficient strategy toward the synthesis of a wide range
of azasugars. In this respect, the new building block 1
constitutes an ideal starting material for natural product
synthesis and design of new glycosidase inhibitors. The
potential flexibility of our approach is currently being
studied.
Hexah ydr o-3-ph en yl-6,7,8-tr ih ydr oxy-3R-[3r,5â,6r,7â,8r,-
8a â]-5H-oxa zolo[3,2-a ]p yr id in e-5-ca r bon itr ile (5): crystal-
lization from THF; mp ) 156-158 °C; [R]25 _155 (c ) 1 in
D
MeOH); 1H NMR (300 MHz, DMSO-d6, 25 °C): δ 3.63 (t, J )
7.5 Hz, 1H), 3.75-3.85m, 2H), 3.85-4.00 (m, 3H), 4.25 (t, J )
7.5 Hz, 1H), 4.49 (d, J ) 1 Hz, 1H), 4.80 (d, J ) 6 Hz, 1H), 5.09
(d, J ) 8 Hz, 1H), 5.46 (d, J ) 3.5 Hz, 1H), 7.2-7.4 (m, 5H); 13
C
NMR (75 MHz, CD3OD, 25 °C) δ 51.9, 64.3, 70.5, 71.8, 74.6, 89.2,
115.5, 129.0, 129.6, 130.0, 137.7; MS (CI, CH4) m/z 277 (M +
1)+.
Hexa h yd r o-3-p h en yl-6,7,8-tr ih yd r oxy-3S[3â,5r,6r,7â,8r,-
8a r]-5H-oxa zolo[3,2-a ]p yr id in e-5-ca r bon itr ile (7): identical
procedure as for 1. [R]25 +134 (c ) 1 in MeOH).
D
Hexa h yd r o-3-p h en yl-6,7,8-tr ih yd r oxy-3S[3â,5r,6â,7r,8â,-
8a r]-5H-oxa zolo[3,2-a ]p yr id in e-5-ca r bon itr ile (8): identical
procedure as for 5. [R]25 +150 (c ) 1 in MeOH); MS (CI) m/z
D
163 (M + 1)+; HRMS (FAB+, Na+) m/z (M + Na)+; calcd for
C6H15N2O3Na: 299.1007, found: 299.1001.
(2R ,3S ,4S ,5R )-2-(Am in om e t h yl)p ip e r id in e -3,4,5-t r iol
(9): a solution of 1 (100 mg, 0.36 mmol) in ethanol (18 mL) was
added to a 1 N HCl ethanolic solution (2 mL) and hydrogenated
at 10 bar over Pd/C/10% for 2 days. After filtration the mixture
was evaporated to dryness. The residue was triturated in THF/
Et2O (1:1) to remove phenylethanol.The remaining precipitate
was dried to give the hygroscopic hydrochloride salt of compound
9 (77 mg, 90%) as a yellowish powder: [R]20 _9.5 (c ) 1.5 in
D
H2O); 1H NMR (300 MHz, D2O, 25 °C): δ 3.15-3.45 (m, 4H),
3.75 (td, J ) 6, 3 Hz, 1H), 3.85-43.95 (m, 3H); 13C NMR (75
MHz, D2O, 25 °C) δ 40.4; 48.2, 54.8, 68.0, 69.3, 69.9; MS (CI)
m/z 163 (M + 1)+; HRMS (FAB+) m/z (M + 1)+; calcd for
C6H15N2O3: 163.1083, found: 163.1078.
(2R ,3R ,4R ,5S )-2-(Am in om e t h yl)p ip e r id in e -3,4,5-t r iol
(11): dichlorhydrate obtained by the same procedure as for
9: [R]25 +8 (c ) 1 in H2O); 1H NMR (400 MHz, D2O, 25 °C): δ
Exp er im en ta l Section
D
2.88 (t, J ) 11.5 Hz, 1H), 3.10-3.25 (m, 2H), 3.28 (m, 1H), 3.36
(m, 2H), 3.46 (t, J ) 10 Hz, 1H), 3.59 (ddd, J ) 5, 9, 11.5 Hz,
1H); 13C NMR (75 MHz, D2O, 25 °C) δ 42.40; 49.0, 57.9, 69.3,
73.8, 78.5; MS (CI) m/z 163 (M + 1)+; HRMS (FAB+) m/z (M +
1)+; calcd for C6H15N2O3: 163.1083, found: 163.1078.
All new compounds were characterized by 2D 1H and 13C NMR
as well as IR spectra, [R] values, simple and high-resolution mass
spectrometry, or elemental analysis.
Hexah ydr o-3-ph en yl-6,7,8-tr ih ydr oxy-3R-[3r,5â,6â,7r,8â,-
8a â]-5H-oxa zolo[3,2-a ]p yr id in e-5-ca r bon itr ile (1): (R)-(-)-
Su p p or tin g In for m a tion Ava ila ble: Experimental pro-
cedures and characterization data for compounds 1, 5, 7, 9,
11, and their NMR spectra viz. 1H, 13C, 2D experiments,
ORTEP plots, and X-ray data for 5. This material is available
(11) (a) Kilonda, A., Compernolle, F.; Toppet, S.; Hoornaert, G. J .
J . Chem. Soc. Chem. Commun. 1994, 2147. (b) Kilonda, A.; Comper-
nolle, F.; Peeters, K.; J oly, G. J .; Toppet, S.; Hoornaert, G. J .
Tetrahedron 2000, 56, 1005-1012.
(12) The numbering of compound 9 follows the usual nomenclature
while nojirimycin, mannojirimycin, and several analogues are num-
bered by some authors according to the sugar nomenclature.
J O000434C